Status:
COMPLETED
Tranexamic Acid in Preventing Postpartum Hemorrhage in High Risk Pregnancies During Elective Cesarean Section
Lead Sponsor:
Mansoura University
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
20-42 years
Phase:
PHASE2
PHASE3
Brief Summary
postpartum hemorrhage (PPT) represents one of the major causes of maternal mortality . Tranexamic acid is used in many studies in management of PPH in combination with ecobolics. this study aims to ev...
Eligibility Criteria
Inclusion
- Gestational age of 28 weeks or more.
- Chronic Hypertension.
- Preeclapmsia -Eclampsia.
- Multiple pregnancy.
- Uterine Liomyomas.
- Polyhydraminos.
- Fetal macrosomia.
- Associated Thrombocytopenia
- History of postpartum hemorrhage.
Exclusion
- Patients with rheumatic heart disease.
- Patients with history Cardiac Valve Replacement.
- Current or past history of DVT.
- Women on any anticoagulant therapy.
- Sensitivity to tranexamic acid
- Pregnancies with any abnormally implanted or located placenta.
Key Trial Info
Start Date :
August 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2017
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT03351686
Start Date
August 1 2016
End Date
April 15 2017
Last Update
November 27 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.